Body Vision Medical Enters into Agreement with HugeMed
7 February 2024
Body Vision Medical has forged a strategic partnership with Shenzhen HugeMed Medical Technical Development to exclusively distribute single-use bronchoscopes for pulmonary procedures in the United States. This collaboration also extends access to HugeMed's bronchoscopes through Body Vision's international distribution network, where the company maintains a sales presence.
With a rising demand for lung cancer screening globally, there is an anticipated surge in the number of patients requiring lung nodule biopsies. Body Vision aims to democratize medical technologies to empower healthcare institutions worldwide in conducting lung nodule biopsies more effectively, efficiently, and affordably.
The addition of HugeMed's single-use bronchoscopes complements Body Vision's LungVision™ AI-driven image guidance system and Mediflex Bronchoscope Stabilization System (BSS). This comprehensive solution positions Body Vision as a leading provider of lung nodule biopsy solutions, offering a clinically competitive alternative to expensive combined robot-assisted bronchoscopy (RAB) and cone-beam CT (CBCT) setups, with greater accessibility to hospitals worldwide.